ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Atea to study AT-527 as monotherapy and in combination for Covid-19
December 16, 2021Atea Pharmaceuticals has announced an update to its strategy to use AT-527 as a single agent and in combination against the SARS-CoV-2 virus and the new variants. -
Atea to terminate Covid-19 drug development deal with Roche
November 18, 2021Atea Pharmaceuticals has announced plans to terminate a strategic partnership with Roche to co-develop the former’s experimental oral direct-acting antiviral pill, AT-527, to treat Covid-19. -
Atea reports positive Phase I data from oral antiviral agent trial for Covid-19
March 09, 2021Atea Pharmaceuticals has reported that results from the Phase I study of oral antiviral agent AT-527 showed it was well tolerated with a favourable safety profile in healthy volunteers.
Pharma Sources Insight January 2025
